Sunday, 17 October 2021


Korean firm Nanos transforms existing production facility to launch cancer drugs

06 April 2021 | News

To establish long-term production and sale of therapeutic drugs

Image credit- shutterstock.com

Image credit- shutterstock.com

Corden Pharma of Germany has entered into a technology alliance agreement with Nanos, based in South Korea, relating to the production of Peptides.

Nanos is a top supplier of camera modules for Samsung Electronics’ mobile phone business.

Due to a relocation of Samsung Electronics’ mobile business to Vietnam, Nanos’ manufacturing factory in Hwasung, Korea, remains out of production.

Through in-licensing or a large-scale direct investment, Nanos plans to transform and utilize the existing production facility to launch high value products, such as Peptides, a potential agent for cancer immunotherapy drugs.

Nanos’ partnership with CordenPharma, one of the leading global development and manufacturing organizations (CDMO), represents Nanos’ strategic intention to establish long-term production and sale of therapeutic drugs involving Peptides, which are currently in Phase 2 clinical trials.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account